Margaret A Harmon

Title: The Innovations of Margaret A. Harmon

Introduction

Margaret A. Harmon is a notable inventor based in Irving, TX (US). She has made significant contributions to the field of biological sciences, particularly in the modulation of processes mediated by retinoid X receptors. Her work has implications for the treatment of various diseases, showcasing her innovative spirit and dedication to advancing medical science.

Latest Patents

Margaret A. Harmon holds a patent for "Selective modulation of processes mediated by retinoid X receptors." This patent describes the discovery of ligands that selectively bind to retinoid X receptors. These ligands can be utilized for the selective modulation of processes mediated by these receptors. Furthermore, the patent includes pharmaceutical compositions that comprise a pharmaceutically acceptable vehicle containing at least one of the selective ligands. Such compositions are particularly useful for treating a variety of retinoid X receptor-mediated disease states.

Career Highlights

Harmon has established her career at the Salk Institute for Biological Studies, where she has been able to collaborate with leading scientists in her field. Her innovative research has led to advancements in understanding how retinoid X receptors function and how they can be targeted for therapeutic purposes.

Collaborations

Some of her notable coworkers include Ronald Mark Evans and David John Mangelsdorf. Their collaborative efforts have contributed to the success of her research and the development of her patented innovations.

Conclusion

Margaret A. Harmon exemplifies the spirit of innovation in the scientific community. Her work on retinoid X receptors not only highlights her inventiveness but also has the potential to impact medical treatments significantly.